Fibroblast-derived exosomes contribute to chemoresistance through priming cancer stem cells in colorectal cancer

PLoS ONE

Volumn 10, Issue 5, 2015, Pages

  Hu, Yibing ^a   Yan, Chang ^a   Mu, Lei ^a   Huang, Kaiyu ^a   Li, Xiaolan ^a   Tao, Deding ^a   Wu, Yaqun ^a   Qin, Jichao ^a  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CD133 ANTIGEN; FLUOROURACIL; GREEN FLUORESCENT PROTEIN; OXALIPLATIN; WNT3A PROTEIN; CONDITIONED MEDIUM; GLYCOPROTEIN; LEUKOCYTE ANTIGEN; PEPTIDE; PROM1 PROTEIN, HUMAN; PROM1 PROTEIN, MOUSE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN EXPRESSION; ARTICLE; CANCER STEM CELL; CARCINOMA ASSOCIATED FIBROBLAST; CELL DEATH; CELL ISOLATION; CLONOGENESIS; COLORECTAL CANCER; COLORECTAL CANCER CELL LINE; CONTROLLED STUDY; CULTURE MEDIUM; DRUG TARGETING; EXOSOME; FEMALE; FIBROBLAST; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; TUMOR GROWTH; TUMOR XENOGRAFT; WNT SIGNALING PATHWAY; ANIMAL; COLORECTAL TUMOR; CONDITIONED MEDIUM; DRUG EFFECTS; DRUG RESISTANCE; DRUG SCREENING; METABOLISM; NUDE MOUSE; PARACRINE SIGNALING; PATHOLOGY; PHARMACOLOGY; TUMOR CELL LINE; ULTRASTRUCTURE;

AC133 ANTIGEN; ANIMALS; ANTIGENS, CD; CELL LINE, TUMOR; COLORECTAL NEOPLASMS; CULTURE MEDIA, CONDITIONED; DRUG RESISTANCE, NEOPLASM; EXOSOMES; FEMALE; FIBROBLASTS; GLYCOPROTEINS; HUMANS; MICE, NUDE; NEOPLASTIC STEM CELLS; PARACRINE COMMUNICATION; PEPTIDES; WNT SIGNALING PATHWAY; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 84929378248     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0125625     Document Type: Article

References (43)

1. Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA: a cancer journal for clinicians. 2011; 61(2):69-90. doi: 10.3322/caac.20107 PMID: 21296855.
2. Ricci-Vitiani L, Lombardi DG, Pilozzi E, Biffoni M, Todaro M, Peschle C, et al. Identification and expansion of human colon-cancer-initiating cells. Nature. 2007; 445(7123):111-5. doi: 10.1038/nature05384 PMID: 17122771.
3. O'Brien CA, Pollett A, Gallinger S, Dick JE. A human colon cancer cell capable of initiating tumour growth in immunodeficient mice. Nature. 2007; 445(7123):106-10. doi: 10.1038/nature05372 PMID: 17122772.
4. Wilson BJ, Schatton T, Zhan Q, Gasser M, Ma J, Saab KR, et al. ABCB5 identifies a therapy-refractory tumor cell population in colorectal cancer patients. Cancer research. 2011; 71(15):5307-16. doi: 10.1158/0008-5472.CAN-11-0221 PMID: 21652540; PubMed Central PMCID: PMC3395026.
5. Brennen WN, Rosen DM, Wang H, Isaacs JT, Denmeade SR. Targeting carcinoma-associated fibroblasts within the tumor stroma with a fibroblast activation protein-activated prodrug. Journal of the National Cancer Institute. 2012; 104(17):1320-34. doi: 10.1093/jnci/djs336 PMID: 22911669; PubMed Central PMCID: PMC3529592.
6. Loeffler M, Kruger JA, Niethammer AG, Reisfeld RA. Targeting tumor-associated fibroblasts improves cancer chemotherapy by increasing intratumoral drug uptake. The Journal of clinical investigation. 2006; 116(7):1955-62. doi: 10.1172/JCI26532 PMID: 16794736; PubMed Central PMCID: PMC1481657.
7. Chairoungdua A, Smith DL, Pochard P, Hull M, Caplan MJ. Exosome release of beta-catenin: a novel mechanism that antagonizes Wnt signaling. The Journal of cell biology. 2010; 190(6):1079-91. doi: 10.1083/jcb.201002049 PMID: 20837771; PubMed Central PMCID: PMC3101591.
8. Boelens MC, Wu TJ, Nabet BY, Xu B, Qiu Y, Yoon T, et al. Exosome transfer from stromal to breast cancer cells regulates therapy resistance pathways. Cell. 2014; 159(3):499-513. doi: 10.1016/j.cell.2014.09.051 PMID: 25417103.
9. Trajkovic K, Hsu C, Chiantia S, Rajendran L, Wenzel D, Wieland F, et al. Ceramide triggers budding of exosome vesicles into multivesicular. Science. 2008; 319(5867):1244-7. doi: 10.1126/science.1153124 PMID: 18309083.
10. Qin J, Liu X, Laffin B, Chen X, Choy G, Jeter CR, et al. The PSA(-/lo) prostate cancer cell population harbors self-renewing long-term tumor-propagating cells that resist castration. Cell stem cell. 2012; 10(5):556-69. doi: 10.1016/j.stem.2012.03.009 PMID: 22560078; PubMed Central PMCID: PMC3348510.
11. Hu X, Yu J, Zhou X, Li Z, Xia Y, Luo Z, et al. Synergism between upregulation of Rab7 and inhibition of autophagic degradation caused by mycoplasma facilitates intracellular mycoplasma infection. Molecular medicine reports. 2014; 9(3):793-800. doi: 10.3892/mmr.2014.1907 PMID: 24452847; PubMed Central PMCID: PMC3926517.
12. Shackleton M, Quintana E, Fearon ER, Morrison SJ. Heterogeneity in cancer: cancer stem cells versus clonal evolution. Cell. 2009; 138(5):822-9. doi: 10.1016/j.cell.2009.08.017 PMID: 19737509.
13. Dallas NA, Xia L, Fan F, Gray MJ, Gaur P, van Buren G 2nd, et al. Chemoresistant colorectal cancer cells, the cancer stem cell phenotype, and increased sensitivity to insulin-like growth factor-I receptor inhibition. Cancer research. 2009; 69(5):1951-7. doi: 10.1158/0008-5472.CAN-08-2023 PMID: 19244128; PubMed Central PMCID: PMC3198868.
14. Dylla SJ, Beviglia L, Park IK, Chartier C, Raval J, Ngan L, et al. Colorectal cancer stem cells are enriched in xenogeneic tumors following chemotherapy. PloS one. 2008; 3(6):e2428. doi: 10.1371/journal.pone.0002428 PMID: 18560594; PubMed Central PMCID: PMC2413402.
15. Lakshman M, Subramaniam V, Rubenthiran U, Jothy S. CD44 promotes resistance to apoptosis in human colon cancer cells. Experimental and molecular pathology. 2004; 77(1):18-25. doi: 10.1016/j.yexmp.2004.03.002 PMID: 15215046.
16. Todaro M, Alea MP, Di Stefano AB, Cammareri P, Vermeulen L, Iovino F, et al. Colon cancer stem cells dictate tumor growth and resist cell death by production of interleukin-4. Cell stem cell. 2007; 1(4):389-402. doi: 10.1016/j.stem.2007.08.001 PMID: 18371377.
17. Meads MB, Gatenby RA, Dalton WS. Environment-mediated drug resistance a major contributor to minimal residual disease. Nat Rev Cancer. 2009; 9(9):665-74. doi: 10.1038/nrc2714 PMID: 19693095.
18. Kinugasa Y, Matsui T, Takakura N. CD44 expressed on cancer-associated fibroblasts is a functional molecule supporting the stemness and drug resistance of malignant cancer cells in the tumor microenvironment. Stem cells. 2014; 32(1):145-56. doi: 10.1002/stem.1556 PMID: 24395741.
19. Mertens JC, Fingas CD, Christensen JD, Smoot RL, Bronk SF, Werneburg NW, et al. Therapeutic effects of deleting cancer-associated fibroblasts in cholangiocarcinoma. Cancer research. 2013; 73(2):897-907. doi: 10.1158/0008-5472.CAN-12-2130 PMID: 23221385; PubMed Central PMCID: PMC3549008.
20. Lotti F, Jarrar AM, Pai RK, Hitomi M, Lathia J, Mace A, et al. Chemotherapy activates cancer-associated fibroblasts to maintain colorectal cancer-initiating cells by IL-17A. The Journal of experimental medicine. 2013; 210(13):2851-72. doi: 10.1084/jem.20131195 PMID: 24323355; PubMed Central PMCID: PMC3865474.
21. Vermeulen L, Melo FDSE, Heijden Mvd, Cameron K, Jong JHd, Borovski T, et al. Wnt activity defines colon cancer stem cells and is regulated by the microenvironment. Nature cell biology. 2010; 12(5):468-76. doi: 10.1038/ncb2048 PMID: 20418870.
22. Orimo A, Gupta PB, Sgroi DC, Arenzana-Seisdedos F, Delaunay T, Naeem R, et al. Stromal fibroblasts present in invasive human breast carcinomas promote tumor growth and angiogenesis through elevated SDF-1/CXCL12 secretion. Cell. 2005; 121(3):335-48. doi: 10.1016/j.cell.2005.02.034 PMID: 15882617.
23. Gonda TA, Varro A, Wang TC, Tycko B. Molecular biology of cancer-associated fibroblasts: can these cells be targeted in anti-cancer therapy? Seminars in cell & developmental biology. 2010; 21(1):2-10. doi: 10.1016/j.semcdb.2009.10.001 PMID: 19840860; PubMed Central PMCID: PMC3531978.
24. Park JE, Lenter MC, Zimmermann RN, Garin-Chesa P, Old LJ, Rettig WJ. Fibroblast activation protein, a dual specificity serine protease expressed in reactive human tumor stromal fibroblasts. J Biol Chem. 1999; 274(51):36505-12. doi: 10.1074/jbc.274.51.36505 PMID: 10593948.
25. Iliou MS, da Silva-Diz V, Carmona FJ, Ramalho-Carvalho J, Heyn H, Villanueva A, et al. Impaired DICER1 function promotes stemness and metastasis in colon cancer. Oncogene. 2014; 33(30):4003-15. doi: 10.1038/onc.2013.398 PMID: 24096488; PubMed Central PMCID: PMC4114136.
26. Dijkgraaf EM, Heusinkveld M, Tummers B, Vogelpoel LT, Goedemans R, Jha V, et al. Chemotherapy alters monocyte differentiation to favor generation of cancer-supporting M2 macrophages in the tumor microenvironment. Cancer research. 2013; 73(8):2480-92. doi: 10.1158/0008-5472.CAN-12-3542 PMID: 23436796.
27. Wang J, Hendrix A, Hernot S, Lemaire M, De Bruyne E, Van Valckenborgh E, et al. Bone marrow stromal cell-derived exosomes as communicators in drug resistance in multiple myeloma cells. Blood. 2014; 124(4):555-66. doi: 10.1182/blood-2014-03-562439 PMID: 24928860.
28. Zhou W, Fong MY, Min Y, Somlo G, Liu L, Palomares MR, et al. Cancer-secreted miR-105 destroys vascular endothelial barriers to promote metastasis. Cancer cell. 2014; 25(4):501-15. doi: 10.1016/j.ccr.2014.03.007 PMID: 24735924; PubMed Central PMCID: PMC4016197.
29. Yen TH, Wright NA. The gastrointestinal tract stem cell niche. Stem Cell Rev. 2006; 2(3):203-12. doi: 10.1007/s12015-006-0048-1 PMID: 17625256.
30. Reya T, Duncan AW, Ailles L, Domen J, Scherer DC, Willertk K, et al. A role for Wnt signalling in self-renewal of haematopoietic stem cells. Nature. 2003; 423(6938):409-14. doi: 10.1038/nature01593 PMID: 12717450.
31. Brabletz T, Jung A, Reu S, Porzner M, Hlubek F, Kunz-Schughart LA, et al. Variable beta-catenin expression in colorectal cancers indicates tumor progression driven by the tumor environment. Proceedings of the National Academy of Sciences of the United States of America. 2001; 98(18):10356-61. doi: 10.1073/pnas.171610498 PMID: 11526241; PubMed Central PMCID: PMC56965.
32. Fodde R, Brabletz T. Wnt/beta-catenin signaling in cancer stemness and malignant behavior. Current opinion in cell biology. 2007; 19(2):150-8. doi: 10.1016/j.ceb.2007.02.007 PMID: 17306971.
33. He T-C, Sparks AB, Rago C, Hermeking H, Zawel L, Costa LTd, et al. Identification of c-MYC as a target of the APC pathway. Science. 1998; 281(5382):1509-12. doi: 10.1126/science.281.5382.1509 PMID: 9727977.
34. Tetsu O, McCormick F. β-catenin regulates expression of cyclin D1 in colon carcinoma cells. Nature. 1999; 398(6726):422-6. doi: 10.1038/18884 PMID: 10201372.
35. Elsaba TM, Martinez-Pomares L, Robins AR, Crook S, Seth R, Jackson D, et al. The stem cell marker CD133 associates with enhanced colony formation and cell motility in colorectal cancer. PloS one. 2010; 5(5):e10714. doi: 10.1371/journal.pone.0010714 PMID: 20502714; PubMed Central PMCID: PMC2873293.
36. Fan F, Bellister S, Lu J, Ye X, Boulbes DR, Tozzi F, et al. The requirement for freshly isolated human colorectal cancer (CRC) cells in isolating CRC stem cells. British journal of cancer. 2015; 112(3):539-46. doi: 10.1038/bjc.2014.620 PMID: 25535733.
37. Visvader JE, Lindeman GJ. Cancer stem cells: current status and evolving complexities. Cell stem cell. 2012; 10(6):717-28. doi: 10.1016/j.stem.2012.05.007 PMID: 22704512.
38. Ratajczak J, Miekus K, Kucia M, Zhang J, Reca R, Dvorak P, et al. Embryonic stem cell-derived microvesicles reprogram hematopoietic progenitors: evidence for horizontal transfer of mRNA and protein delivery. Leukemia. 2006; 20(5):847-56. doi: 10.1038/sj.leu.2404132 PMID: 16453000.
39. Valadi H, Ekstrom K, Bossios A, Sjostrand M, Lee JJ, Lotvall JO. Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells. Nature cell biology. 2007; 9(6):654-9. doi: 10.1038/ncb1596 PMID: 17486113.
40. Mittelbrunn M, Sanchez-Madrid F. Intercellular communication: diverse structures for exchange of genetic information. Nature reviews Molecular cell biology. 2012; 13(5):328-35. doi: 10.1038/nrm3335 PMID: 22510790; PubMed Central PMCID: PMC3738855.
41. Kowal J, Tkach M, Thery C. Biogenesis and secretion of exosomes. Current opinion in cell biology. 2014; 29C:116-25. doi: 10.1016/j.ceb.2014.05.004 PMID: 24959705.
42. Luga V, Zhang L, Viloria-Petit AM, Ogunjimi AA, Inanlou MR, Chiu E, et al. Exosomes mediate stromal mobilization of autocrine Wnt-PCP signaling in breast cancer cell migration. Cell. 2012; 151(7):1542-56. doi: 10.1016/j.cell.2012.11.024 PMID: 23260141.
43. Peinado H, Aleckovic M, Lavotshkin S, Matei I, Costa-Silva B, Moreno-Bueno G, et al. Melanoma exosomes educate bone marrow progenitor cells toward a pro-metastatic phenotype through MET. Nature medicine. 2012; 18(6):883-91. doi: 10.1038/nm.2753 PMID: 22635005; PubMed Central PMCID: PMC3645291.